Kane Biotech Inc. KNE.V Stock
Kane Biotech Inc. Price Chart
Kane Biotech Inc. KNE.V Financial and Trading Overview
| Kane Biotech Inc. stock price | 0.13 CAD |
| Previous Close | 0.1 CAD |
| Open | 0.1 CAD |
| Bid | 0.09 CAD x 0 |
| Ask | 0.1 CAD x 0 |
| Day's Range | 0.1 - 0.1 CAD |
| 52 Week Range | 0.08 - 0.15 CAD |
| Volume | 11K CAD |
| Avg. Volume | 54.58K CAD |
| Market Cap | 11.86M CAD |
| Beta (5Y Monthly) | 0.257816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KNE.V Valuation Measures
| Enterprise Value | 21.77M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.265532 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.83 |
| Enterprise Value/EBITDA | -7.279 |
Trading Information
Kane Biotech Inc. Stock Price History
| Beta (5Y Monthly) | 0.257816 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 CAD |
| 52 Week Low | 0.08 CAD |
| 50-Day Moving Average | 0.11 CAD |
| 200-Day Moving Average | 0.1 CAD |
KNE.V Share Statistics
| Avg. Volume (3 month) | 54.58K CAD |
| Avg. Daily Volume (10-Days) | 32.82K CAD |
| Shares Outstanding | 124.85M |
| Float | 90.5M |
| Short Ratio | 0.09 |
| % Held by Insiders | 26.82% |
| % Held by Institutions | 0% |
| Shares Short | 5K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -143.22% |
| Operating Margin (ttm) | -112.85% |
| Gross Margin | 56.63% |
| EBITDA Margin | -107.57% |
Management Effectiveness
| Return on Assets (ttm) | -35.19% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.78M CAD |
| Revenue Per Share (ttm) | 0.02 CAD |
| Quarterly Revenue Growth (yoy) | 19.80% |
| Gross Profit (ttm) | 1.41M CAD |
| EBITDA | -2991190 CAD |
| Net Income Avi to Common (ttm) | -3982403 CAD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 990.08K CAD |
| Total Cash Per Share (mrq) | 0.008 CAD |
| Total Debt (mrq) | 7.94M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.389 |
| Book Value Per Share (mrq) | -0.062 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3178550 CAD |
| Levered Free Cash Flow (ttm) | -3102984 CAD |
Profile of Kane Biotech Inc.
| Country | Canada |
| State | MB |
| City | Winnipeg |
| Address | 290-100 Innovation Drive |
| ZIP | R3T 6G2 |
| Phone | 204 453 1301 |
| Website | https://kanebiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Q&A For Kane Biotech Inc. Stock
What is a current KNE.V stock price?
Kane Biotech Inc. KNE.V stock price today per share is 0.13 CAD.
How to purchase Kane Biotech Inc. stock?
You can buy KNE.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kane Biotech Inc.?
The stock symbol or ticker of Kane Biotech Inc. is KNE.V.
Which industry does the Kane Biotech Inc. company belong to?
The Kane Biotech Inc. industry is Biotechnology.
How many shares does Kane Biotech Inc. have in circulation?
The max supply of Kane Biotech Inc. shares is 131.85M.
What is Kane Biotech Inc. Price to Earnings Ratio (PE Ratio)?
Kane Biotech Inc. PE Ratio is now.
What was Kane Biotech Inc. earnings per share over the trailing 12 months (TTM)?
Kane Biotech Inc. EPS is -0.03 CAD over the trailing 12 months.
Which sector does the Kane Biotech Inc. company belong to?
The Kane Biotech Inc. sector is Healthcare.